GBI Biomanufacturing
Plantation, FL, United States gbibio.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
GBI Biomanufacturing is a full-service biopharmaceutical CDMO based in Plantation, Florida. It supports biologics programs from process development and scale-up through cGMP clinical and commercial manufacturing for bulk drug substance and vialed drug product.
Services
SmartScale™ GMP Platform
Gene-to-GMP vial manufacturing service for first-in-human biologics programs using a purpose-built platform.
CDMO: development & manufacturing
Analytical Method Development, Assay Verification, and Characterization
Develops, verifies, and characterizes analytical and cell-based assays for biologics through cGMP manufacturing.
Aseptic Fill & Finish
Provides cGMP aseptic liquid fill-finish services for clinical trial material in vials, syringes, and cartridges.
CDMO: development & manufacturing
Antibody-Oligonucleotide Conjugate (AOC) Development
Supports process development, scale-up, and manufacturing of antibody-oligonucleotide conjugates.
Bioconjugation
Offers proof-of-concept, development, optimization, and cGMP manufacturing for a range of bioconjugates.
cGMP Cell Banking
Manufactures and stores research, master, working, and end-of-production cell banks under cGMP conditions.
Cell line development
cGMP Clinical & Commercial Manufacturing
Performs cGMP manufacturing of bulk drug substance and vialed drug product for clinical and commercial supply.
CDMO: development & manufacturing
DSP Purification Development
Develops downstream purification processes for biologics manufacturing.
CDMO: development & manufacturing
8 more services
- Stability Testing
- Upstream Processing
- Cell Culture Development
- Manufacturing Strategy Development
- Project Management
- Regulatory & CMC Support
- Quality Control & Quality Assurance
- Biomanufacturing Planning
- Turnaround
- 8 months for standard biologics
- As fast as 5 months for radioimmunoconjugate programs
- What to send
- 100 mg of drug substance mentioned as an early-phase need
Capabilities
- Assays and studies
- Antibodies
- Fill-finish
- Analytical development
- Stability studies
- Oligonucleotides
- Process development
17 more
- Bispecifics
- Bioreactors
- HPLC
- ELISA
- Reverse phase HPLC
- Size exclusion HPLC
- Ion exchange HPLC
- HIC
- HILIC
- Capillary electrophoresis
- CE-SDS (R/NR)
- icIEF
- SDS-PAGE (R/NR)
- IEF
- Protein A HPLC
- Western blot
- UV/Vis protein concentration assays
- Scale and capacity
- 38,000 ft² manufacturing and process development facility
- 5,000 ft² extended warehouse space
- 200L bioreactors
- 500L bioreactors
- 2,000L bioreactors
- Three dedicated process trains
6 more
- Up to 2,000 vials per batch
- Up to 10,000 vials automated fill finish
- Up to 400 cartridges
- Up to 3,000 vials per batch in 2R, 6R and 10R fill formats
- Stirred tank bioreactors from 250 mL to 40 L
- Multiple 5L stirred tank bioreactors
- Therapeutic areas
- Biologics
- Complex biologic therapeutics
- Theranostics
- Imaging
- Vaccine development
- Oncology
Instruments and platforms
- AST GENiSYS C
- VSM-10
- VSM-20
- XCell™ ATF 2
- XCell™ ATF 6
- ÄKTA™ systems
- Mettler Toledo Advanced Synthesis system
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Peptide
- Oligonucleotide
- Recombinant protein
- Vaccine
- Species and models
- Mammalian cell culture
- CHO-like production cell lines
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing, cell banking, fill-finish, and clinical/commercial supply
Details
- Type
- CDMO
- Founded
- 1992
- Office
- Manufacturing 3 Expedited CMC Strategy What It Is ATUM’s Leap-In ® Transpos
- Serves
- US, Europe, Asia, worldwide